scholarly journals Intratumoral concentration of estrogens and clinicopathological changes in ductal carcinoma in situ following aromatase inhibitor letrozole treatment

2013 ◽  
Vol 109 (1) ◽  
pp. 100-108 ◽  
Author(s):  
K Takagi ◽  
T Ishida ◽  
Y Miki ◽  
H Hirakawa ◽  
Y Kakugawa ◽  
...  
Cancer ◽  
2016 ◽  
Vol 123 (6) ◽  
pp. 940-947 ◽  
Author(s):  
Hui Zhao ◽  
Nainan Hei ◽  
Yiling Wu ◽  
Winston Chan ◽  
Xiudong Lei ◽  
...  

Author(s):  
Stephen Kinsey-Trotman ◽  
Zumin Shi ◽  
Beverley Fosh

This review paper analyzed publications of adjuvant tamoxifen and aromatase inhibitor use following surgery for breast ductal carcinoma in situ (DCIS). Key endpoint analyses were risk of invasive and noninvasive malignancies and new contralateral breast cancers. Meta-analysis of three studies showed a relative risk of 0.69 (95% confidence interval, 0.60-0.79, P<0.05) for breast malignancies with tamoxifen treatment in a mixed radiotherapy treatment/naïve cohort. Subgroup analysis of DCIS populations in multiple studies showed a trend to benefit with aromatase inhibitor treatment.


1999 ◽  
Vol 41 (6) ◽  
pp. 1225
Author(s):  
Eung Yeop Kim ◽  
Boo Kyung Han ◽  
Yeon Hyeon Choe ◽  
Seok Jin Nam ◽  
Young Hyeh Ko ◽  
...  

2019 ◽  
Author(s):  
Gemma M Wilson ◽  
Barbara J Guild ◽  
Christine L Clarke ◽  
Nirmala Pathmanathan ◽  
J Dinny Graham

Sign in / Sign up

Export Citation Format

Share Document